Nuvation Bio NUVB
NYSE NUVB
$5.63 +0.03 (+0.45%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nuvation Bio (NUVB) Gross Margin (2024 - 2025)

Updated

Nuvation Bio's Gross Margin was 74.47% in Q3 2025, up 182.86 percentage points from -108.39% a year earlier and up 27.77 percentage points from the prior quarter.

Analysis

Nuvation Bio (NUVB) Gross Margin (2024 - 2025) Analysis & Trends

On a trailing twelve-month basis, Nuvation Bio's Gross Margin was 54.26% through Sep 30, 2025, up 86.64 percentage points year-over-year; for FY2024, it came in at 10.10%.

  • Per Business Quant data, NUVB's Gross Margin in the three quarters before Q3 2025 was 46.70% (Q2 2025), 32.10% (Q1 2025) and 26.18% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Nuvation Bio 1.94 Bn 1.94 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 74.47%
Jun 30, 2025 46.70%
Mar 31, 2025 32.10%
Dec 31, 2024 26.18%
Sep 30, 2024 -108.39%
Jun 30, 2024 6.13%
API Access

Nuvation Bio Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=NUVB&period=max&api_key=YOUR_API_KEY